Additional lots of losartan recalled due to potential cancer risk

Michael Walter | | Cardiovascular Business | Heart Health
Recall | Product recall

Sandoz Canada and Sanis Health are recalling all lots of prescription losartan tablets due to the presence of an azido impurity above the acceptable limit. The impurity is a mutagen and can create a heightened cancer risk over time if allowed to rise above certain levels.

The news, announced in a new advisory from Health Canada, marks the latest in a series of recalls of antihypertensive medications in Canada over the last several months. Previous recalls have included losartan, irbesartan and valsartan—all were related to the same azido impurity.

“Continue taking your medication unless you have been advised to stop by your healthcare provider,” Health Canada warned in its advisory. “Not treating your condition may pose a greater health risk.”

Read the full advisory—which includes all updates since the first announcement back in May—here.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Medtronic receives key FDA clearance, launches new diabetes system
Martha Gulati highlights 'exciting' progress in preventive cardiology
Abbott opens CGM sensor manufacturing facility in Ireland as part of $465M investment
Cardiologist examines the latest breakthroughs in coronary inflammation research
Tirzepatide linked to significant weight loss, ‘impressive’ diabetes prevention after 3 years
No-contact blood pressure and diabetes screening with AI shows promise

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."